UK Drug Safety Update · June 20, 2024

Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme

Topiramate is now contraindicated in pregnancy and women of childbearing potential unless a Pregnancy Prevention Programme is fulfilled.

Low obligation Product class Pharmaceuticals UK Pharmacovigilance

Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless the conditions of a Pregnancy Prevention Programme are fulfilled. This follows a review by the MHRA which concluded that the use of…

Read the official source ↗

Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.